Mortality Up for Individuals Who Need Hospital-Based Care for Cannabis Addiction

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 12, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 12, 2025 -- Individuals who require hospital-based care for cannabis use disorder (CUD) have an increased risk for premature death, according to a study published online Feb. 6 in JAMA Network Open.

Daniel T. Myran, M.D., M.P.H., from the University of Ottawa in Canada, and colleagues examined whether individuals receiving incident hospital-based care for CUD have an increased risk for death in a population-based retrospective cohort study. Overall and cause-specific mortality were compared between individuals with incident hospital-based CUD care and age- and sex-matched members of the general population. The matched analysis included 527,972 individuals; 106,994 had incident CUD.

The researchers found that 3.5 percent of individuals died within five years of incident hospital-based CUD care compared with 0.6 percent of matched general population controls. Individuals with incident hospital-based CUD care had an increased risk for death compared with the general population after adjustment for comorbid conditions (adjusted hazard ratio, 2.79). Relative to the general population, individuals with hospital-based CUD care had an increased risk for all investigated types of death and a particularly elevated risk for death by suicide, trauma, opioid poisoning, other drug poisonings, and lung cancer (adjusted hazard ratios, 9.70, 4.55, 5.03, 4.56, and 3.81, respectively). Individuals with hospital-based care for alcohol, stimulants, and opioids had a relatively increased risk for death within five years compared with those with hospital-based care for CUD (adjusted hazard ratios, 1.30, 1.69, and 2.19, respectively).

"The results of this cohort study suggest that individuals who require hospital-based care for a CUD are at an elevated risk of premature death," the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Stay up to date on the latest in health—subscribe to our weekly newsletter!

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-13 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords